Why the study?
Standardizing definitions for ADHF and its trajectory is complex, limiting the generalizability and translation of clinical trials to clinical care and policy change.
This expert consensus document proposes standardized definitions for acute decompensated heart failure to improve the design, conduct, and generalizability of clinical trials.
Answers are grounded in this paper and cite their sources.
Standardized ADHF definitions should now guide trial design and endpoint selection; extends prior consensus to improve generalizability of heart failure studies.
Acute decompensated heart failure (ADHF) is one of the most common reasons for hospitalizations or urgent care and is associated with poor outcomes. Therapies shown to improve outcomes are limited, however, and innovation in pharmacologic and device-based therapeutics are therefore actively being sought. Standardizing definitions for ADHF and its trajectory is complex, limiting the generalizability and translation of clinical trials to effect clinical care and policy change. The Heart Failure Collaboratory is a multistakeholder organization comprising clinical investigators, clinicians, patients, government representatives (including U.S. Food and Drug Administration and National Institutes of Health participants), payors, and industry collaborators. The following expert consensus document is the product of the Heart Failure Collaboratory convening with the Academic Research Consortium, including members from academia, the U.S. Food and Drug Administration, and industry, for the purposes of proposing standardized definitions for ADHF and highlighting important endpoint considerations to inform the design and conduct of clinical trials for drugs and devices in this clinical arena.
No takes yet. Share an insight, caveat, or question.
Lala et al. (2023) conducted a review in Acute decompensated heart failure (ADHF). Standardized definitions for ADHF was evaluated. Standardized definitions for acute decompensated heart failure and endpoint considerations were proposed to inform the design and conduct of clinical trials for drugs and devices.
Synapse has enriched 10 related papers. Consider them for comparative context: